Evidence map›Paper›PMID 27385972›Full record

ArticleJournal of family & reproductive health2016

Comparison Pregnancy Outcomes Between Minimal Stimulation Protocol and Conventional GnRH Antagonist Protocols in Poor Ovarian Responders.

Shamim Pilehvari, Ensieh ShahrokhTehraninejad, Batool Hosseinrashidi, Fatemeh Keikhah, Fedyeh Haghollahi, Elham Aziminekoo

Registry-linked trialAbstract read
In one paragraph

Article in Journal of family & reproductive health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06778733 (The Effect of Clomiphene Citrate Administration in Combination with Low Dose), which is not on this map. Cited by 16 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06778733 early_phase1completednot on this mapstarted 2022, after this paper: background citation

The Effect of Clomiphene Citrate Administration in Combination with Low Dose (150 IU) of Gonadotropins Vs High Dose Gonadotropin Protocol in Poor Responders. Impact on Stimulation Characteristics and Pregnancy Outcome.

TypeinterventionalSponsorUniversity of AthensRan2022 to 2024Enrolled22ConditionsFemale InfertilityArmsClomiphane citrate, recombinant human Follicle-Stimulating Hormone (r-FSH-alfa)
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Editorial: The Expansion of Female Fertility.Frontiers in reproductive health · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shamim PilehvariReproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Ensieh ShahrokhTehraninejadReproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Batool HosseinrashidiReproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Fatemeh KeikhahReproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Fedyeh HaghollahiReproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Elham AziminekooReproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare the pregnancy outcomes achieved by in vitro fertilization (IVF) between minimal stimulation and conventional antagonist protocols in poor ovarian responders (PORs). MATERIALS AND

methodsIn this randomized controlled trial, 77 PORs undergoing IVF were selected and divided into two groups. First group was the minimal stimulation group (n = 42) receiving 100 mg/day clomiphene citrate on day 2of the cycle for 5 day that was followed by150IU/day human menopausal gonadotropin (hMG) on day 5 of the cycle. Second group was the conventional group (n = 35) receiving at least 300 IU/daygonadotropin on day 2 of the cycle. Gonadotropin-releasing hormone (GnRH) antagonist protocol was applied for both groups according to flexible protocol. Number of retrieved oocytes and chemical pregnancy rate were the main outcomes.

resultsThere was no difference in number ofretrieved oocyte and pregnancy rate (2.79 ± 1.96 vs. 2.20 ± 1.71 and 5.6% vs. 4.1%; p > 0.05) between both groups. The gonadotropin dose used in the minimal stimulation group was lower than conventional group (1046 ± 596 vs. 2806 ± 583).

conclusionMinimal stimulation protocol with lower gonadotropin used is likely to be considered as a patient- friendly and cost-effective substitute for PORs.

Indexed as

Conventional Antagonist ProtocolIn Vitro FertilizationMinimal Stimulation ProtocolPoor Ovarian Responders

Identifiers

PMID27385972
PMCPMC4930452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.